首页> 外国专利> New therapeutic agent for the treatment of infertility and / or male subfertility in mammals.

New therapeutic agent for the treatment of infertility and / or male subfertility in mammals.

机译:用于治疗哺乳动物不育和/或男性不育的新型治疗剂。

摘要

New therapeutic agent for the treatment of infertility and / or male subfertility in mammals. Trans-resveratrol induces an increase in sperm concentration due to an increase in sperm tissue as a whole. It also induces an increase in the serum concentration of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone, which implies a hyposphysial stimulation in the hypothalamic-pituitary-testicular axis. Unlike other medications proposed for the treatment of male infertility, trans-resveratrol is useful for the treatment of male infertility and / or subfertility caused by different causes such as idiopathic infertility, elevated levels of reactive oxygen species or inflammatory disorders . It is advantageous that trans-resveratrol has several mechanisms of action, since male infertility and / or subfertility generally has multiple convergent causes.
机译:用于治疗哺乳动物不育和/或男性不育的新型治疗剂。由于整个精子组织的增加,反式白藜芦醇引起精子浓度的增加。它还会引起卵泡刺激素(FSH),促黄体生成素(LH)和睾丸激素的血清浓度增加,这暗示着下丘脑-垂体-睾丸轴的次物理刺激。与建议用于治疗男性不育症的其他药物不同,反式白藜芦醇可用于治疗由不同原因引起的男性不育症和/或亚生育力,这些原因包括特发性不育症,活性氧水平升高或炎症性疾病。反式白藜芦醇具有多种作用机制是有利的,因为男性不育和/或亚不育通常具有多种会聚原因。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号